Kasper Jakobsen Named President and Chief Executive Officer of Mead Johnson Nutrition
Jakobsen, 51, succeeds Stephen W. Golsby, who had previously announced his retirement.
“Throughout his career at Mead Johnson, Kasper has displayed a keen understanding of our operations, our customers, our markets, and the issues that drive this industry,” said Jim Cornelius, Mead Johnson Nutrition’s Chairman of the Board. “The Board looks forward to working with him and his entire leadership team, while at the same time continuing to benefit from the experience and insights of Steve Golsby, who has been reelected as a Director.”
Jakobsen was designated CEO-Elect and was appointed to the company’s
Board of Directors in
Previously, Jakobsen served as President of the company’s business in
the
Jakobsen joined Mead Johnson in 1998 as head of marketing in
Prior to joining
Jakobsen holds a bachelor’s degree in commerce from
Forward-Looking Statements
Certain statements in this news release are forward-looking as defined
in the Private Securities Litigation Reform Act of 1995. These
forward-looking statements may be identified by the fact they use words
such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,”
“project,” “guidance,” “intend,” “plan,” “believe” and other words and
terms of similar meaning and expression. Such statements are likely to
relate to, among other things, a discussion of goals, plans and
projections regarding financial position, results of operations, cash
flows, market position, product development, product approvals, sales
efforts, expenses, capital expenditures, performance or results of
current and anticipated products and the outcome of contingencies such
as legal proceedings and financial results. Forward-looking statements
can also be identified by the fact that they do not relate strictly to
historical or current facts. Such forward-looking statements are based
on current expectations that involve inherent risks, uncertainties and
assumptions that may cause actual results to differ materially from
expectations as of the date of this news release. These risks include,
but are not limited to: (1) the ability to sustain brand strength,
particularly the Enfa family of brands; (2) the effect on the company's
reputation of real or perceived quality issues; (3) the effect of
regulatory restrictions related to the company’s products; (4) the
adverse effect of commodity costs; (5) increased competition from
branded, private label, store and economy-branded products; (6) the
effect of an economic downturn on consumers' purchasing behavior and
customers' ability to pay for product; (7) inventory reductions by
customers; (8) the adverse effect of changes in foreign currency
exchange rates; (9) the effect of changes in economic, political and
social conditions in the markets where we operate; (10) changing
consumer preferences; (11) the possibility of changes in the Women,
Infant and Children (WIC) program, or participation in WIC; (12)
legislative, regulatory or judicial action that may adversely affect the
company's ability to advertise its products or maintain product margins;
and (13) the ability to develop and market new, innovative products. For
additional information regarding these and other factors, see the
company’s filings with the
About Mead Johnson
Mead Johnson, a global leader in pediatric nutrition, develops, manufactures and distributes more than 70 products sold in over 50 markets worldwide. The company’s mission is to nourish the world’s children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products over 100 years. The company’s “Enfa” family of brands, including Enfamil® infant formula, is the world’s leading brand franchise in pediatric nutrition. For more information on company, go to www.meadjohnson.com.
Source:
Mead Johnson Nutrition
Investors:
Kathy
MacDonald, (847) 832-2182
kathy.macdonald@mjn.com
or
Media:
Christopher
Perille, (847) 832-2178
chris.perille@mjn.com
4/30/2013